Page last updated: 2024-11-08

amifampridine and Disease Models, Animal

amifampridine has been researched along with Disease Models, Animal in 9 studies

Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"While chronic pain is a main symptom in endometriosis, the underlying mechanisms and effective therapy remain elusive."1.38Ectopic uterine tissue as a chronic pain generator. ( Alvarez, P; Chen, X; Giudice, LC; Green, PG; Hendrich, J; Irwin, JC; Levine, JD, 2012)
"Verapamil toxicity was produced in all animals following an average dose of 1."1.29Hemodynamic effects of 3,4-diaminopyridine in a swine model of verapamil toxicity. ( Martin, TG; Menegazzi, JJ; Plewa, MC; Seaberg, DC; Wolfson, AB, 1994)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's3 (33.33)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Vazquez-Cintron, E1
Machamer, J1
Ondeck, C1
Pagarigan, K1
Winner, B1
Bodner, P1
Kelly, K1
Pennington, MR1
McNutt, P1
Jones, AK1
Rayes, D1
Al-Diwani, A1
Maynard, TP1
Jones, R1
Hernando, G1
Buckingham, SD1
Bouzat, C1
Sattelle, DB1
Mori, S1
Kishi, M1
Kubo, S1
Akiyoshi, T1
Yamada, S1
Miyazaki, T1
Konishi, T1
Maruyama, N1
Shigemoto, K1
Alvarez, P1
Chen, X1
Hendrich, J1
Irwin, JC1
Green, PG1
Giudice, LC1
Levine, JD1
van Lunteren, E2
Moyer, M2
Plewa, MC1
Martin, TG1
Menegazzi, JJ1
Seaberg, DC1
Wolfson, AB1
Kamijo, T1
Tomaru, T1
Miwa, A1
Nakamura, F1
Kido, H1
Sugimoto, T1
Uchida, Y1

Other Studies

9 other studies available for amifampridine and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Symptomatic treatment of botulism with a clinically approved small molecule.
    JCI insight, 2020, 01-30, Volume: 5, Issue:2

    Topics: Amifampridine; Animals; Antitoxins; Botulinum Toxins; Botulinum Toxins, Type A; Botulism; Disease Mo

2020
A Cys-loop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC-63 impairs but does not abolish channel function.
    The Journal of biological chemistry, 2011, Jan-28, Volume: 286, Issue:4

    Topics: 4-Aminopyridine; Amifampridine; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Ch

2011
3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis.
    Journal of neuroimmunology, 2012, Volume: 245, Issue:1-2

    Topics: 4-Aminopyridine; Amifampridine; Animals; Autoantibodies; Disease Models, Animal; Female; Mice; Myast

2012
Ectopic uterine tissue as a chronic pain generator.
    Neuroscience, 2012, Dec-06, Volume: 225

    Topics: 4-Aminopyridine; Action Potentials; Amifampridine; Animals; Antineoplastic Agents, Hormonal; Biophys

2012
Improvement of dy/dy dystrophic diaphragm by 3,4-diaminopyridine.
    Muscle & nerve, 2002, Volume: 26, Issue:1

    Topics: 4-Aminopyridine; Amifampridine; Animals; Diaphragm; Disease Models, Animal; Electric Stimulation; Ho

2002
Sternohyoid muscle fatigue properties of dy/dy dystrophic mice, an animal model of merosin-deficient congenital muscular dystrophy.
    Pediatric research, 2003, Volume: 54, Issue:4

    Topics: 4-Aminopyridine; Amifampridine; Animals; Disease Models, Animal; Electric Stimulation; Humans; In Vi

2003
Hemodynamic effects of 3,4-diaminopyridine in a swine model of verapamil toxicity.
    Annals of emergency medicine, 1994, Volume: 23, Issue:3

    Topics: 4-Aminopyridine; Amifampridine; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; F

1994
[The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1992, Volume: 100, Issue:4

    Topics: 4-Aminopyridine; Amifampridine; Animals; Benzopyrans; Coronary Vasospasm; Cromakalim; Disease Models

1992